作者:
Saad,F. [1]
;
Brown,J.E. [2]
;
VanPoznak,C. [3]
;
Ibrahim,T. [4]
;
Stemmer,S.M. [5]
;
Stopeck,A.T. [6]
;
Diel,I.J. [7]
;
Takahashi,S. [8]
;
Shore,N. [9]
;
Henry,D.H. [10]
;
Barrios,C.H. [11]
;
Facon,T. [12]
;
Senecal,F. [13]
;
Fizazi,K. [14]
;
Zhou,L. [15]
;
Daniels,A. [16]
;
Carrière,P. [17]
;
Dansey,R.
作者单位:
Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
[1]
Carolina Urologic Research Center, Myrtle Beach, SC, United States
[2]
Clinical Development, Amgen Inc., Thousand Oaks, CA, United States
[3]
Institute for Gynecologic Oncology, Center for Comprehensive Gynecology, Mannheim, Germany
[4]
Department of Blood Diseases, H?pital Claude Huriez, Lille, France
[5]
Department of Medicine, University of Arizona, Arizona Cancer Center, Tucson, AZ, United States
[6]
Internal Medicine Department, Pontifícia Universidade Católica do Rio Grande do Sul School of
[7]
Institute of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Campus, Petah-Tiqva, Israel
[8]
Cancer Research UK Clinical Centre, University of Leeds, Leeds, United Kingdom
[9]
Global Biostatistical Sciences, Amgen Inc., Thousand Oaks, CA, United States
[10]
Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA, United States
[11]
Northwest Medical Specialties, Tacoma, WA, United States
[12]
Department of Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France
[13]
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
[14]
Global Safety, Amgen Inc., Thousand Oaks, CA, United States
[15]
The Cancer Institute Hospital of JFCR, Tokyo, Japan
[16]
Department of Urology, University of Montreal, Montreal, QC, Canada
[17]
发布时间
2013-11-20